Posted by Michael Wonder on 06 Apr 2020
Medicines Australia and the Generic and Biosimilar Medicines Association granted interim authorisation by the ACCC
3 April 2020 - In an important collaborative step, Medicines Australia and the Generic and Biosimilar Medicines Association have today been granted ACCC Authorisation to permit discussions and the implementation of strategies that support the continued supply of essential medicines and associated supplies to Australians, including those urgently needed for the treatment of COVID-19.
This authorisation reflects the critical need to stabilise and manage the supply of medicines which has seen unprecedented demand in recent weeks resulting from the COVID-19 pandemic.
Maintaining the supply of essential medicines to Australians who rely on them is the industry’s utmost priority as we face one of the biggest global health challenges of our time.
